ANAB$46.991.55%-0.74
After Hours: 47.73+0.74 +1.57%
Anaptysbio Inc (ANAB)
Date: 2026-11-04 16:00O: 49.00H: 49.00L: 45.81C: 47.56Vol: 411.1k
Anaptysbio Inc stock is traded at $46.99, with a volume of 155,166. It is down -1.55% in the last 24 hours and down -3.17% over the past month. AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Previous Close:
$47.73
Open:
$49.00
24h Volume:
155,166
Relative Volume:
0.41
Market Cap:
$1.40B
Revenue:
$232.39M
Net Income/Loss:
-$26.79M
P/E Ratio:
-
EPS:
-$1.08
Net Cash Flow:
$4.41M
1W Performance:
-6.95%
1M Performance:
-3.17%
6M Performance:
-32.66%
1Y Performance:
+35.26%
1-Day Range:
$45.81$49.00
1-Week Range:
$45.81$51.22
52-Week Range:
$30.27$73.30
Anaptysbio Inc Stock (ANAB) Company Profile
Name
Anaptysbio IncSector
HealthcareIndustry
BiotechnologyPhone
858-362-6295Address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
Anaptysbio Inc Stock (ANAB) Financials Data
Anaptysbio Inc Stock (ANAB) Insider Trading
- RENTON HOLLINGSOct 01 '26Director
- Transaction
- Option Exercise
- Cost
- $18.03
- #Shares
- 5,000
- Value ($)
- 90,150
- #Shares Total
- 15,995
- RENTON HOLLINGSOct 01 '26Director
- Transaction
- Sale
- Cost
- $49.87
- #Shares
- 5,000
- Value ($)
- 249,372
- #Shares Total
- 10,995
- HOLLINGS C RENTONOct 01 '26Director
- Transaction
- Proposed Sale
- Cost
- $49.87
- #Shares
- 5,000
- Value ($)
- 249,372
- #Shares Total
- 0
- Orwin John ASep 15 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,300
- Value ($)
- 0
- #Shares Total
- 17,995
- JOE ANTHONY WAREJul 13 '26Director
- Transaction
- Proposed Sale
- Cost
- $67.17
- #Shares
- 10,694
- Value ($)
- 718,333
- #Shares Total
- 0
- JOE ANTHONY WAREJun 30 '26Director
- Transaction
- Proposed Sale
- Cost
- $67.79
- #Shares
- 6,030
- Value ($)
- 408,774
- #Shares Total
- 0
- DENNIS MULROYJun 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $63.45
- #Shares
- 9,476
- Value ($)
- 601,213
- #Shares Total
- 0
- DENNIS MULROYJun 26 '26Officer
- Transaction
- Proposed Sale
- Cost
- $60.82
- #Shares
- 10,000
- Value ($)
- 608,183
- #Shares Total
- 0
- DENNIS MULROYJun 17 '26Officer
- Transaction
- Proposed Sale
- Cost
- $60.00
- #Shares
- 850
- Value ($)
- 51,000
- #Shares Total
- 0
- DENNIS MULROYJun 16 '26Officer
- Transaction
- Proposed Sale
- Cost
- $60.00
- #Shares
- 1,265
- Value ($)
- 75,900
- #Shares Total
- 0
